Patent · US Active

Compositions and methods for decreasing tau expression

US11473083B2 · kind B2 · utility

0Cited by

49References

10Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Manuela Polydoro Ofengeim · Brookline, US
Jan Weiler · Cambridge, US

Key dates

Filing date	Dec 19, 2016
Grant date	Oct 18, 2022
Priority date	—
Expiry date	Dec 19, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions and methods for decreasing tau mRNA and protein expression. These compositions and methods are useful in treating tau-related diseases and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.